Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study.

Smach MA, Jacob N, Golmard JL, Charfeddine B, Lammouchi T, Ben Othman L, Dridi H, Bennamou S, Limem K.

Eur Neurol. 2011;65(5):270-8. doi: 10.1159/000326301. Epub 2011 Apr 8.

PMID:
21474939
2.

Biomarkers of folate and vitamin B12 are related in blood and cerebrospinal fluid.

Obeid R, Kostopoulos P, Knapp JP, Kasoha M, Becker G, Fassbender K, Herrmann W.

Clin Chem. 2007 Feb;53(2):326-33. Epub 2007 Jan 2.

4.

[Plasma, red cell, and cerebrospinal fluid folate in Alzheimer's disease].

Abalan F, Zittoun J, Boutami C, Dugrais G, Manciet G, Decamps A, Antoniol B.

Encephale. 1996 Nov-Dec;22(6):430-4. French.

PMID:
10901835
5.

CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.

Smach MA, Charfeddine B, Lammouchi T, Harrabi I, Ben Othman L, Dridi H, Bennamou S, Limem K.

Neurosci Lett. 2008 Aug 1;440(2):145-9. doi: 10.1016/j.neulet.2008.05.076. Epub 2008 May 24.

PMID:
18555606
6.

CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment.

Stefani A, Martorana A, Bernardini S, Panella M, Mercati F, Orlacchio A, Pierantozzi M.

J Neurol Sci. 2006 Dec 21;251(1-2):124-8. Epub 2006 Nov 9.

PMID:
17097109
7.

Relations between homocysteine, folate and vitamin B12 in vascular dementia and in Alzheimer disease.

Köseoglu E, Karaman Y.

Clin Biochem. 2007 Aug;40(12):859-63. Epub 2007 Apr 27.

PMID:
17532313
8.

Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.

Diamandis EP, Scorilas A, Kishi T, Blennow K, Luo LY, Soosaipillai A, Rademaker AW, Sjogren M.

Clin Biochem. 2004 Mar;37(3):230-7.

PMID:
14972646
9.

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, Vanderstichele H, Vanmechelen E, Blennow K.

Arch Neurol. 1999 Jun;56(6):673-80.

PMID:
10369305
10.

CSF/serum folate gradient: physiology and determinants with special reference to dementia.

Hagnelius NO, Wahlund LO, Nilsson TK.

Dement Geriatr Cogn Disord. 2008;25(6):516-23. doi: 10.1159/000129696. Epub 2008 May 7.

PMID:
18463447
11.

Elevated homocysteine levels in patients with slow coronary flow: relationship with Helicobacter pylori infection.

Evrengul H, Tanriverdi H, Kuru O, Enli Y, Yuksel D, Kilic A, Kaftan A, Kirac S, Kilic M.

Helicobacter. 2007 Aug;12(4):298-305.

PMID:
17669101
12.

Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.

Parnetti L, Tiraboschi P, Lanari A, Peducci M, Padiglioni C, D'Amore C, Pierguidi L, Tambasco N, Rossi A, Calabresi P.

Biol Psychiatry. 2008 Nov 15;64(10):850-5. doi: 10.1016/j.biopsych.2008.02.016. Epub 2008 Apr 8.

PMID:
18395699
13.

Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.

Rentzos M, Paraskevas GP, Kapaki E, Nikolaou C, Zoga M, Rombos A, Tsoutsou A, Vassilopoulos D D.

J Neurol Sci. 2006 Nov 15;249(2):110-4. Epub 2006 Jul 14.

PMID:
16843497
14.

Evaluation of cerebrospinal fluid tau/beta-amyloid(42) ratio as diagnostic markers for Alzheimer disease.

Smach MA, Charfeddine B, Ben Othman L, Lammouchi T, Dridi H, Nafati S, Ltaief A, Bennamou S, Limem K.

Eur Neurol. 2009;62(6):349-55. doi: 10.1159/000241881. Epub 2009 Sep 26.

PMID:
19786779
15.

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttilä T.

Arch Neurol. 2009 Mar;66(3):382-9. doi: 10.1001/archneurol.2008.596.

PMID:
19273758
17.

Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia.

Jia JP, Meng R, Sun YX, Sun WJ, Ji XM, Jia LF.

Neurosci Lett. 2005 Jul 22-29;383(1-2):12-6. Epub 2005 Apr 25.

PMID:
15936505
18.

[Plasma levels of endogenous hydrogen sulfide and homocysteine in patients with Alzheimer's disease and vascular dementia and the significance thereof].

Liu XQ, Liu XQ, Jiang P, Huang H, Yan Y.

Zhonghua Yi Xue Za Zhi. 2008 Aug 19;88(32):2246-9. Chinese.

PMID:
19087670
19.

Genetic polymorphisms involved in folate metabolism and concentrations of methylmalonic acid and folate on plasma homocysteine and risk of coronary artery disease.

Biselli PM, Guerzoni AR, de Godoy MF, Eberlin MN, Haddad R, Carvalho VM, Vannucchi H, Pavarino-Bertelli EC, Goloni-Bertollo EM.

J Thromb Thrombolysis. 2010 Jan;29(1):32-40. doi: 10.1007/s11239-009-0321-7. Epub 2009 Mar 13.

PMID:
19283448

Supplemental Content

Support Center